External negatives threaten pharmaceutical industry

Published: 2007-11-22 07:00:00

Updated: 2007-11-22 07:00:00

A host of new external negatives have emerged over the past weeks, further casting a shadow over the long-term prospect of local pharmaceutical industry in terms of research and development projects.

The heavy fine by the Free Trade Commission over undue business practice of 10 pharmaceutical ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK